[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100500566":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":25,"centralContacts":29,"locations":36,"responsibleParty":50,"collaborators":34,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":34,"eligibilityCriteria":58,"healthyVolunteers":59,"sex":60,"minAge":61,"maxAge":34,"enrollmentInfo":62,"targetDuration":34,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":34,"overallStatus":71,"whyStopped":34,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Daewoong Pharmaceutical Co. LTD.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"DWP16001 to Group A","EXPERIMENTAL","Group A: Fasting in Period 1 \u002F Fed in Period 2",[13],"Drug: DWP16001",{"label":15,"type":10,"description":16,"interventionNames":17},"DWP16001 to Group B","Group B: Fed in Period 1 \u002F Fasting in Period 2",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DRUG","DWP16001","DWP16001 0.3mg",[9,15],[22],[26],{"name":27,"affiliation":27,"role":28},"Chungbuk National University Hospital","PRINCIPAL_INVESTIGATOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":34,"email":35},"Daewoong Pharmaceutical","CONTACT","080-550-8308",null,"yoonhye@daewoong.co.kr",[37],{"facility":27,"status":38,"city":39,"state":34,"zip":34,"country":40,"countryCode":34,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"RECRUITING","Taebuk","South Korea",{"type":42,"coordinates":43},"Point",[44,45],128.56667,36.26667,{"lat":45,"lon":44},[48],{"name":49,"role":32,"phone":34,"phoneExt":34,"email":34},"Jun Gi Hwang",{"type":51,"investigatorFullName":34,"investigatorTitle":34,"investigatorAffiliation":34,"oldNameTitle":34,"oldOrganization":34},"SPONSOR","100500566","phase-1-to-evaluate-the-effect-of-food-on-the-safety-and-pk-characteristics-of-dwp16001-in-healthy-adult-volunteers-100500566",false,"NCT05797922","To Evaluate the Effect of Food on the Safety and PK Characteristics of DWP16001 in Healthy Adult Volunteers","A Phase 1 Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetics and Safety of DWP16001 After Administration in Healthy Adult Volunteers","Inclusion Criteria:\n\n1. A person who has decided to participate voluntarily and agreed in writing prior to the screening procedure after understanding the detailed explanation of this clinical trial.\n2. A person who is 19 years of age or more at the time of screening.\n3. Those with a weight of 50.0 kg or more and a body mass index (BMI) of 18.0 kg\u002Fm2 or more and 30.0 kg\u002Fm2 or less.\n\nExclusion Criteria:\n\n1. A person who has a genetic problem such as galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption.\n2. A person who has a history of gastrointestinal surgery\u002Fdisease, such as Crohn's disease, ulcer, acute or chronic pancreatitis, which may affect the absorption of drug for clinical trials. (Except for simple appendectomy or hernia surgery)",true,"ALL","19 Years",{"count":63,"type":64},32,"ESTIMATED","INTERVENTIONAL",[67],"PHASE1","This study aims to evaluate the effect of food on the pharmacokinetics and safety of DWP16001 after oral administration.",[70],"Healthy","UNKNOWN","2023-04-03",{"date":74,"type":75},"2023-04-04","ACTUAL",{"date":77,"type":75},"2023-03-09",{"date":79,"type":64},"2023-11-30",{"name":5,"class":6},1]